Optimax to raise RM21m from IPO
KUALA LUMPUR: Optimax Holdings Bhd (OHB), which currently operates 13 specialist centres in Malaysia, aims to raise RM21 million from its initial public offering (IPO), whereby the bulk of it or RM10.35 million, will be utilised for its expansion plans.
Chief executive officer Sandy Tan said the company’s immediate plans will be to expand its ambulatory care centre network in the central region of Peninsular Malaysia.
“This addresses the potential needs of urban communities in this densely populated region.
“Part of the proceeds from the IPO will go towards equipping our Seremban specialist centre and purchasing the property to convert this centre to an ambulatory care centre.
“We are also purchasing new equipment and tools for existing centres as part of plans to upgrade the equipment as well as increase our services and expand our capacity,” she told reporters during the launching of OHB’s prospectus today.
Apart from 13 eye specialist centres spread across the northern, central and southern regions of Peninsular Malaysia as well as East Malaysia, the company has one specialist hospital, 11 ambulatory care centres and one specialist clinic.
These centres are either fully-owned or jointly-owned with resident eye surgeons.
OHB’s team of specialists comprises 18 eye surgeons and 33 optometrists.
Touching further on the IPO, Tan said the rest of the gross proceeds will be used to repay borrowings (RM3.52 million), finance its capital working requirement (RM3.53 million), and listing expenses (RM3.6 million).
The IPO entails a public issue of 70 million IPO shares at the issue price of 30 sen per share, of which 13.5 million shares will be made available for the Malaysian public, four million shares for Optimax’s eligible directors and employees and 52.5 million shares for institutional and selected investors.
OHB targets to list on the ACE Market of Bursa Malaysia Securities Bhd on August 18.
Affin Hwang Bank Bhd is OHB’s principal adviser, sole placement agent, sole underwriter and sponsor in relation to the IPO.
Source: NST
